David M. Nathan,John M. Lachin,Ashok Balasubramanyam,Henry B. Burch,John B. Buse,Nicole M. Butera,Robert M. Cohen,Jill P. Crandall,Steven E. Kahn,Heidi Krause‐Steinrauf,Mary Larkin,Neda Rasouli,Margaret Tiktin,Deborah J. Wexler,Naji Younes
The comparative effectiveness of glucose-lowering medications for use with metformin to maintain target glycated hemoglobin levels in persons with type 2 diabetes is uncertain.